<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02184910</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0722</org_study_id>
    <nct_id>NCT02184910</nct_id>
  </id_info>
  <brief_title>Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is well-known that atrophic gastritis is a major risk factor for gastric cancer, which
      leads to variations in the serum levels of gastrin, pepsinogen (PG) I, and PGII. We want to
      assess the effects of age, sex, and Helicobacter pylori status on pepsinogen (PG) level for
      atrophic gastritis and whether gastric atrophy based on the PG test would be improved after
      H. pylori eradication.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Years</target_duration>
  <primary_outcome>
    <measure>the change of pepsinogen level before and after H. pylori eradication</measure>
    <time_frame>baseline and 6 months</time_frame>
    <description>to compare the change of the pepsinogen level before and after H. pylori eradication and evaluate the correlation between the pepsinogen level and the atrophic gastritis</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Atrophic Gastritis</condition>
  <arm_group>
    <arm_group_label>gastritis and pepsinogen</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pepsinogen and gastrin</intervention_name>
    <arm_group_label>gastritis and pepsinogen</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Over 19 years, the patients who have gastrointestinal discomfort or get
        esophagastroduodenoscopy (EGD) for health check up, the patients who got the procedure,
        endoscopic submucosal resection (ESD) for early gastric cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. over 19 years

          2. the patients who have gastrointestinal discomfort or get esophagogastroduodenoscopy
             (EGD) for health check up

          3. the patients who got the procedure, endoscopic submucosal resection (ESD) for early
             gastric cancer

        Exclusion Criteria:

          1. gastrectomy history

          2. advanced gastric cancer (impossible to get the gastrectomy)

          3. Helicobacter eradication history

          4. the patients who have chronic disease

          5. cancer patients except gastric cancer within 6 months

          6. who cannot perform this study according to research's decision

          7. who have bleeding tendency (ex. taking antiplatelet agent, low platelet count or
             abnormal coagulation time)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yong Chan Lee, MD, PhD</last_name>
    <phone>82-2-2228-1960</phone>
    <email>leeyc@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Severance hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong Chan Lee, MD, PhD</last_name>
      <phone>82-2-2228-1960</phone>
      <email>leeyc@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2014</study_first_submitted>
  <study_first_submitted_qc>July 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2014</study_first_posted>
  <last_update_submitted>July 8, 2014</last_update_submitted>
  <last_update_submitted_qc>July 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>atrophic gastritis, pepsinogen, Helicobacter pylori</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Gastritis</mesh_term>
    <mesh_term>Gastritis, Atrophic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

